MONALEESA-3 was a randomized double-blind, placebo-controlled study of ribociclib together with fulvestrant to the cure of postmenopausal women with hormone receptor good, HER2-destructive, Sophisticated breast cancer who have been given no or only one line of prior endocrine cure.This cure can have an effect on the way your coronary heart works.